{"name":"Yamo Pharmaceuticals LLC","slug":"yamo-pharmaceuticals-llc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMi1wJBVV95cUxQMnRjM0FlUlpnYmpKNWtfRTJHUkc4X3poQW5CZUo5VkRxOTU1bktlQ1dIQmxYamFldDBWS2FmekhqeW91dVYtMWJfT1NpbXhYV2UzWlFibWpIWGpSdzFVelJXSFZZbDVuMjlMZVltelA0Q0ZoSmtQOXVDbUxKZTNfYUNNemhlVE5zTlhRcGo3NVFLVnNzMkNYUFpmN1lVSzZiUE00Tk10WW1ab2pfamFMTlBlTTluNGVtYzl4TVdwSGhZSU41Z2xaQU1nbGUxQVE2TGNYQnBKRXpxbkVRTWJMR29MRjR4aUdmQnp3REJzS0kyU3ZBUVZEWWVUQnAwRnNtX0drQVpQY3RqS2VzUnM1UkxhcUZubXJiWDFEYzNQNmZiWGVzb0dqakNxTVlCeXgtTTFzYV96UGNxblpvdDEwNHpsYVZPZWdLQzV2bVd6cVdUVEV4WFhB?oc=5","date":"2026-04-06","type":"regulatory","source":"Barchart","summary":"Autistic Disorder Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveInsight | Jazz Pharma, Axial Therapeutics, Eli Lilly and Company, Scioto Bioscienc","headline":"Autistic Disorder Pipeline 2026: Therapies Under Investigation, Clinical Trials Milestones, and FDA Approvals by DelveIn","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMirgJBVV95cUxOZFFXbjY5X19SVW9xSlRDdjdlUkgzYnRNbnFFRzU5WjBwUXpyS2xYRm5Sd2sxWndTZ3RpOHFiNEJjbU1CXzg1M3hwSkN5TW1tY05TZG5BMmtGNmZNS1F5WGRxR3F5MzhqSnRzWndvaS0zMGgxQWdfU2VwU1V2ckZxYVVEOGxDRlMzTEVsZm5yU045QWhLWURlTXdRcFhXSXZTb0h0WjVBMklWTTNLVG5hdm04MG1hWUJXUEdUSFlnZHNPT2VuNlFkNXEtVGNXc1FPang4Q09JOVVKMjNTYjB2ZHd3QlVlUC13ZkR2RG5OV0llZ3hicUg5SjdPc1lieXE4eUR0X2lnRTY0SUlDTzRPV1dpQU1tMWRDYjZGTGh1enZpS1RJa2w1SWRtbWF4dw?oc=5","date":"2025-06-26","type":"trial","source":"globenewswire.com","summary":"Autism Spectrum Disorder Clinical Trial Analysis: Key - globenewswire.com","headline":"Autism Spectrum Disorder Clinical Trial Analysis: Key","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxONk9VWmptalh0bEZDMjdhdGtEWWVKeHRMVW05TDlHcFRjTUx4QmUyanRmdHc0eFFKQzdYcmwtQ0loaGRlaU9ldzhXdHhHNTNfcXBWcVhONUJaZXRuN09UY2E0SXlKcFpLNXF3TS1zUDhkZHRqbE5DWjdVeG9feko0eGQ3dHQyN242Wno5ZDBGMC1DY0pZRnZZQnhnZlAxUHB6ZE5Qb3VQV3JvSVR3U1huQXJOU3NmeGxtUXdUQUhPOW5CNEZ0OU51RVA4ZFJOYTExSUh5WHBYanBqc0ZtN0pKaU1nbmJfbDktRWEtcWV6Rzl3aVdPNGIwSA?oc=5","date":"2025-05-08","type":"trial","source":"globenewswire.com","summary":"Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025 - globenewswire.com","headline":"Yamo Pharma Presents Statistically Significant Phase 2 Autism Results for L1-79 at INSAR 2025","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMibkFVX3lxTE1nOTROazBERV9tdzQzNHNBYzNJdnAxdjB6c1RUME14ZGhIMXROUEJzcUpGbkRqbm1tWERkTHB1U3JmVVQ2X3VsVW5ZbVF5QzZVQ0ZUTHF1TE9ialJkZTVtZ05oMXEyZkd2SzBFQU9B?oc=5","date":"2025-02-04","type":"pipeline","source":"UnivDatos","summary":"Autism Spectrum Disorder Market Size, Trends and Forecast (2024-2032) - UnivDatos","headline":"Autism Spectrum Disorder Market Size, Trends and Forecast (2024-2032)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqwJBVV95cUxON2xJUDg4c1pvSURMSVNqaXBURFNNRmtLZ0JpYlBRbWJCNHVRN0JsTG5LQ2dtdnhDelhFaUlSSE5yTUZXSEZHZlJHSEZrUVJDbFhMc2FuSWJhOFM0SlkzZzB5S25zT3gtRG5jTnVVeGo5eXdxYWhfcGIydGpUY1EyYmVuLVFIWDk2MXNpMXphMVhxN1pWMlQ5M0ZkRGNUZGVHd0FZRFRPUE9JM0ZWQ0U4aWN5OFRjVlBVUlVjYVhPUUo3dU9VNG1lYmRabUV4d0ZSbTRuSENnUm5MZmI0RzdsUTQwTndHNGdNYlZwN20xdG1JOGI5ejhfQjBLbWh3eEdFRHctRm9HMWhSMUtXc0lxbXBpY09md3NyZE5GeVpRbFRidS1nRXJ5MG1CTQ?oc=5","date":"2023-11-20","type":"trial","source":"globenewswire.com","summary":"Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study - globenewswire.com","headline":"Yamo Pharmaceuticals Enrolls Final Patient in Phase 2 Study","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimwFBVV95cUxPMjdTQVFFYjE5MDQyNUNzYkk1RllGRGtSSXBBR3ZiMHp4MnZFNkVmLVJKRzhtX1RDaUZZWXB5cjR0RHZDODNLd2x3aExIQUNPY0FsNXQ4aFVBa2RNMGROcnZUajJQZWQ1eXl4emwwNC1Ubi02TExPQ1liVXRvcF9Jc182NGxmZE1jdWJ2T2VpSVo5M3puVExHb2tIQQ?oc=5","date":"2022-10-25","type":"pipeline","source":"BioSpace","summary":"Autism Spectrum Disorder Treatment Market Size, Growth, Report 2022-2030 - BioSpace","headline":"Autism Spectrum Disorder Treatment Market Size, Growth, Report 2022-2030","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMimAFBVV95cUxOTWNwWjQxNGpwS1F3SGhfSjBLLW9sTlY4RUZwVG81QWFNREhFejlxVGpTd3BFLXYzNS1wbXl1dkYtLTVaM1BGOUtXbTVfbnVqZ0FDcVEtdTBxVTExaWVfZnZQYk9vYndPb2Y4bmdQR1FkVjk1QU9qOWlRemFyMktYMEJ6TjNibU10Z2ZYMXFtWVVzX1FnS2hIcQ?oc=5","date":"2021-11-10","type":"trial","source":"Yahoo Finance","summary":"Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Disorder - Yahoo Finance","headline":"Yamo Pharmaceuticals Receives Investment from Autism Impact Fund to Support Phase 2 Study of L1-79 in Autism Spectrum Di","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwAFBVV95cUxPbUJmb0RWSlZfblVneHhBRTU4U1dLRGF0dEcwS2FPMXVzMVFWLW8tUFk1VUZjWHJTcF95V21TdXNteHJlQk5HTEJYaXFDOW1HcVE5TU5rUEUtbDdySWJsb1hkQzRBVWI3bXFRTjN0SGtVSTZ1bEVrQXJTMmFhdFdRZDlBVmtDYTZBdXRtdXdieS1ld01tN1Vob0NNaFJiQWFzZzJUQy1SUXA0ajdDQnd3a3FoMU5WUHlJcGFoTlhiWk4?oc=5","date":"2018-07-13","type":"deal","source":"Fierce Pharma","summary":"Senators challenge Novartis' account of Cohen deal, calling it 'longer and more detailed' than disclosed - Fierce Pharma","headline":"Senators challenge Novartis' account of Cohen deal, calling it 'longer and more detailed' than disclosed","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNa0NKRDAzM20wQkxHbWgxeG1ienhlSUtKRDgzdjNGaDkxREZ4eUw2aC04RnBNZUlDQjdOTkZzT1piREVFVGYxeHFOZmVNVXNYTFg4SkRZQzl2ZmhHN2I4X1hUT2V4MUtld2lReXlrNmgyQ1Jzc0VGdU5PdGVQOUFQZmNlMkY1U2FsZFd6bWNBNnlpMUZ2ZmN0cWhOTE12WE43bUx4dkhuZDA?oc=5","date":"2018-07-13","type":"pipeline","source":"ABC News","summary":"Senate Democrats blast former Trump attorney for 'selling access' to White House - ABC News","headline":"Senate Democrats blast former Trump attorney for 'selling access' to White House","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi-AFBVV95cUxNcVVxWVRtaFZnZzhzOHhYbUV5U3pBVUJqUk8zY3cxUU5FeVVhWlR6S2YyVFhmRC1Yam1taXBQeTNyaE5nQ1JaRnEzXzhnbEhlZGFzd1c5OXQzcXItUHdSc0JlU05reWV1MGFrakl3Z0dLckFzQlZSVGJiNHlHVkE5dklmT3RoeEY1MmtBV3V2XzBMbWstQzkyZ1AtRW96VExuTGtzQ25mZHZhdjFRenlFM1B5V256aGhVLTdmSmJPZ0xhN0Y5UWpFQU5WV0JVRnNjMVNPSDRHZHpiZURHZU43WmFzYWRid21zWU5QcWVRTHdxaHlxRUJCNA?oc=5","date":"2018-05-14","type":"regulatory","source":"globenewswire.com","summary":"FDA Grants Fast Track Designation for Yamo Pharmaceutical’s L1-79 in Autism Spectrum Disorder - globenewswire.com","headline":"FDA Grants Fast Track Designation for Yamo Pharmaceutical’s L1-79 in Autism Spectrum Disorder","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}